Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 19, 2024. According to the Company's Next Day Disclosure Report, the Company has repurchased millions of shares during the above period, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price presents a different degree of discount or premium compared to the market price. The last repurchase took place on April 19, 2024, on which day the company repurchased 474,200 shares of A-shares for a total payment of RMB20,047,645. The share repurchase of this series has been conducted in accordance with the relevant rules and ordinary resolutions and has complied with all necessary legal procedures and listing rules requirements.

Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 19, 2024. According to the Company's Next Day Disclosure Report, the Company has repurchased millions of shares during the above period, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price presents a different degree of discount or premium compared to the market price. The last repurchase took place on April 19, 2024, on which day the company repurchased 474,200 shares of A-shares for a total payment of RMB20,047,645. The share repurchase of this series has been conducted in accordance with the relevant rules and ordinary resolutions and has complied with all necessary legal procedures and listing rules requirements.